Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)

Hangzhou Biotest Biotech Revenue

Hangzhou Biotest Biotech had revenue of 89.38M CNY in the quarter ending March 31, 2026, with 1.70% growth. This brings the company's revenue in the last twelve months to 449.50M, down -12.15% year-over-year. In the year 2025, Hangzhou Biotest Biotech had annual revenue of 448.01M, down -19.91%.

• Revenue (ttm): 449.50M
• Revenue Growth: -12.15%
• P/S Ratio: 13.85
• Revenue / Employee: 745.44K
• Employees: 622
• Market Cap: 6.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	448.01M	-111.39M	-19.91%
Dec 31, 2024	559.40M	117.29M	26.53%
Dec 31, 2023	442.11M	-1.46B	-76.75%
Dec 31, 2022	1.90B	83.07M	4.57%
Dec 31, 2021	1.82B	952.70M	110.09%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 11, 2026

Data Sources Report a data error